Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation

BJU International

Volumn 96, Issue 4, 2005, Pages 553-557

  Leuenroth, Sven ^a   Riethdorf, Sabine ^a   Erbersdobler, Andreas ^a   Riethdorf, Lutz ^a   Löning, Thomas ^a   Huland, Hartwig ^a   Friedrich, Martin G ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Bladder carcinoma; In situ hybridization; Telomerase

Indexed keywords

BCG VACCINE; MITOMYCIN C; RNA; SULFUR 35; TELOMERASE; URIDINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MUCOSA; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE MARKER; EVALUATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROBE; SIGNAL DETECTION; SUPERFICIAL CANCER; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM RECURRENCE, LOCAL; RNA; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 24044548008     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05683.x     Document Type: Article

References (34)

1. Chopin DK, Gattegno B. Superficial bladder tumours. Eur Urol 2002; 42: 533-41
2. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-9
3. Blackburn EH. Telomerases. Annu Rev Biochem 1992; 61: 113-29
4. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68: 3410-4
5. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994; 9: 3043-8
6. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995; 269: 1267-70
7. Friedrich MG, Conrad S, Hautmann S, Schwaibold H, Huland H. Reduction of early tumour recurrences in pTa/pT1 bladder carcinoma using an extended resection protocol. J Urol 2004; 171: 290
8. Sobin LH, Wittekind CH eds, TNM Classification of Malignant Tumours. International Union Against Cancer (UICC), 5th edition. New York: John Wiley & Sons, 1997
9. Milani S, Herbst H, Schuppan D, Kim KY, Riecken EO, Stein H. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 1990; 98: 175-84
10. Friedrich MG, Schwaibold H, Wintzer O, Pichlmaier U, Huland H. P53 accumulation in noncancerous bladder mucosa among patients with superficial transitional cell carcinoma of the bladder: a marker for disease recurrence. Urol Oncol 1998; 3: 125-31
11. Lee E, Schwaibold H, Fradet Y, Huland E, Huland H. Tumour-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder. J Urol 1997; 157: 1070-3
12. Heinzer H, Huland E, Monk M, Huland H. Distribution of 486P, 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder. J Urol 1992; 148: 802-5
13. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999; 154: 721-7
14. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996; 7: 1443-54
15. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476-81
16. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5
17. Feng J, Funk WD, Wang SS et al. The RNA component of human telomerase. Science 1995; 269: 1236-41
18. Meyerson M, Counter CM, Eaton EN et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumour cells and during immortalization. Cell 1997; 90: 785-95
19. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9
20. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumour tissues. Cancer Res 1996; 56: 645-50
21. Heine B, Hummel M, Muller M, Heicappell R, Miller K, Stein H. Nonradioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J Pathol 1998; 184: 71-6
22. Hiyama T, Yokozaki H, Kitadai Y et al. Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis. Virchows Arch 1999; 434: 483-7
23. Kuniyasu H, Domen T, Hamamoto T et al. Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 1997; 88: 103-7
24. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 1997; 150: 1159-64
25. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997; 14: 1013-21
26. Yashima K, Piatyszek MA, Saboorian HM et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997; 50: 110-7
27. Marusic L, Anton M, Tidy A, Wang P, Villeponteau B, Bacchetti S. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol 1997; 17: 6394-401
28. Riethdorf S, Riethdorf L, Schulz G et al. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Int J Gynecol Pathol 2001; 20: 177-85
29. Mutirangura A, Sriuranpong V, Termrunggraunglert W et al. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions. Br J Cancer 1998; 78: 933-9
30. Kyo S, Takakura M, Tanaka M et al. Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions. Clin Cancer Res 1998; 4: 399-405
31. Tsao J, Zhao Y, Lukas J et al. Telomerase activity in normal and neoplastic breast. Clin Cancer Res 1997; 3: 627-31
32. Park TW, Riethdorf S, Riethdorf L, Loning T, Janicke F. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumours. Int J Cancer 1999; 84: 426-31
33. Junker K, Kania K, Fiedler W, Hartmann A, Schubert J, Werner W. Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. Int J Oncol 2002; 20: 647-53
34. Obermann EC, Junker K, Stoehr R et al. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol 2003; 199: 50-7